IBISWorld Platform
Answer any industry question in minutes with our entire database at your fingertips.
Enovis Corp. is a medical technology company that develops, manufactures, and distributes medical devices and services for the Prevention & Recovery and Reconstructive markets. Its product portfolio includes rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators for pain management, and physical therapy products. It also offers a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. It sells and markets to orthopedic specialists, other healthcare professionals, and retail consumers in the US and internationally through independent distributors and a direct sales force. It has manufacturing facilities across Central America, Europe, Africa, and Asia. The firm was incorporated in Delaware on February 25, 1998. Its headquarters are located in Wilmington, Delaware.
IBISWorld's SupplierIQ profile covering Enovis Corp. includes financial statements, products & service markets, competitive position and key financial health ratios.
This SupplierIQ profile on Enovis Corp. covers the company’s financial statements, products & service markets, competitive position and key financial health ratios. Enovis Corp., trading as Enovis, is a public company with 6.8k employees.
Enovis Corp. primarily operates in Surgical Appliance and Supplies Manufacturing, as well as in Medical Equipment and Supplies Manufacturing in the US.
The Product & Service Markets chapter provides a breakdown of Enovis Corp.’s key product and service segments, organized by standardized industry classifications like NAICS. It includes their market share in each of these markets with market share trends and insights.
The Competitive Position chapter covers Enovis Corp.’s performance relative to competitors in each of the products and service markets the company operates in. This includes a detailed competitor matrix comparing the market share, return on assets, return on equity, pricing power and competitive outlook. There are qualitative insights and a detailed SWOT analysis included for each product and service market.
The Income Statement chapter includes datasets covering Enovis Corp.’s historical financial performance. Line items include revenue, cost of sales, gross margins, general and administrative costs, research and development costs, depreciation, interest and taxes. This is available in current and historical datasets.
The Balance Sheet chapter includes datasets covering Enovis Corp.’s historical financial health. Current asset and non-current asset accounts include line items like cash, receivables, inventories, property, plant and equipment, investments, goodwill. Current liabilities and non-current liabilities accounts include line items like accounts payable, debts, provisions and lease liabilities. The equity accounts include line items like paid-in capital, retained earnings, employee stock option plans and treasury stock. This is available in current and historical datasets.
The Cash Flows chapter includes detailed line item accounts covering Enovis Corp.’s operating cash flow activities, financing cash flow activities and investing cash flow activities. This is available in current and historical datasets.
The Ratios chapter covers key financial metrics like the operating margin, gross margin, return on equity, return on assets, current ratio, quick ratio, EBIT margins, EBITDA margins, debt ratio, equity ratio and debt to equity ratios. This is available in current and historical datasets.
More than 6,000 businesses use IBISWorld to shape local and global economies
We were able to supplement our reports with IBISWorld’s information from both a qualitative and quantitative standpoint. All of our reporting now features some level of IBISWorld integration.
IBISWorld delivers the crisp business knowledge we need to drive our business. Whether it be serving up our major clients, winning new business or educating on industry issues, IBISWorld brings real value.
IBISWorld has revolutionised business information — which has proved commercially invaluable to exporters, investors and public policy professionals in Australia and overseas.
When you’re able to speak to clients and be knowledgeable about what they do and the state that they operate in, they’re going to trust you a lot more.
According to the 2024 IBISWorld ProcurementIQ report, Enovis Corp. generated $2.2bn in revenue.
The 2024 ProcurementIQ report benchmarks Enovis Corp. against its top competitors across execution score, operational capabilities, pricing power, and market share.
Enovis Corp.’s EBITDA margin is reported across a 7-year period in the 2024 IBISWorld ProcurementIQ report. The report includes a full income statement breakdown.
The 2024 report identifies all NAICS-coded product and service markets Enovis Corp. participates in, including market share, concentration, profitability trends, and average vendor risk ratings.
The 2024 ProcurementIQ report lists Enovis Corp.’s employee count and benchmarks workforce size against key competitors to assess relative operational capacity.